EUVIMEDEUVIMED entdecken
Crossref

Development of a Quercetin–Resveratrol Microemulsion Hydrogel Using an Isopropyl Myristate–Tween 80 System for Improved Healing of Diabetic Wounds

Dashrath Singh, D. Suresh, Navjot Kanwar, Nilesh Kumar Upadhyay, Avneet Kaur Lamba, Annanya Gangopadhyay, Fahim Ansari, Amit Kumar

International Journal of Drug Delivery Technology · 11.06.2026 · 16 (48s)

DOI: 10.25258/ijddt.16.48s.123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Dashrath Singh und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to develop and evaluate a microemulsion-based hydrogel incorporating quercetin and resveratrol using an isopropyl myristate–Tween 80–polyethylene glycol 400 system for enhanced topical delivery in diabetic wound healing. Solubility studies guided the selection of formulation components, and pseudo-ternary phase diagrams were constructed to identify the microemulsion region. The optimized microemulsion exhibited a droplet size of 118.4 ± 5.6 nm, low polydispersity index, and high entrapment efficiency (86.3 ± 2.1%). Incorporation into a Carbopol 934 hydrogel resulted in a stable, homogeneous formulation with suitable pH and rheological properties for topical application. In vitro drug release studies demonstrated sustained release of both quercetin (91.6 ± 3.1%) and resveratrol (94.3 ± 3.4%) over 24 hours, following Higuchi diffusion kinetics. The formulation showed enhanced permeation with flux values of 35.1 ± 1.02 µg/cm²/h and 37.3 ± 1.08 µg/cm²/h for quercetin and resveratrol, respectively. Antioxidant evaluation revealed superior DPPH radical scavenging activity compared to free drugs. Cell viability studies confirmed biocompatibility, while scratch assay results demonstrated significantly enhanced fibroblast migration (89.6 ± 3.2% wound closure at 48 h). The study concludes that the developed microemulsion-based hydrogel effectively enhances solubility, permeation, and biological activity of quercetin and resveratrol, making it a promising approach for diabetic wound management.

Zitieren

APA

Singh, D., Suresh, D., Kanwar, N., Upadhyay, N. K., Lamba, A. K., Gangopadhyay, A., Ansari, F., & Kumar, A. (2026). Development of a Quercetin–Resveratrol Microemulsion Hydrogel Using an Isopropyl Myristate–Tween 80 System for Improved Healing of Diabetic Wounds. International Journal of Drug Delivery Technology, 16(48s). https://doi.org/10.25258/ijddt.16.48s.123

Vancouver

Singh D, Suresh D, Kanwar N, Upadhyay NK, Lamba AK, Gangopadhyay A, et al. Development of a Quercetin–Resveratrol Microemulsion Hydrogel Using an Isopropyl Myristate–Tween 80 System for Improved Healing of Diabetic Wounds. International Journal of Drug Delivery Technology. 2026;16(48s). doi:10.25258/ijddt.16.48s.123

BibTeX
@article{Singh2026,
  author = {Singh, Dashrath and Suresh, D. and Kanwar, Navjot and Upadhyay, Nilesh Kumar and Lamba, Avneet Kaur and Gangopadhyay, Annanya and Ansari, Fahim and Kumar, Amit},
  title = {Development of a Quercetin–Resveratrol Microemulsion Hydrogel Using an Isopropyl Myristate–Tween 80 System for Improved Healing of Diabetic Wounds},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {48s},
  doi = {10.25258/ijddt.16.48s.123}
}
Kostenlos starten →